Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Capital Reinvestment Ratio
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Capital Reinvestment Ratio of 2.39x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥62.99 Million) in capital expenditures (CN¥150.58 Million). See Tonghua Dongbao Pharmaceutical Co Ltd (600867) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tonghua Dongbao Pharmaceutical Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Tonghua Dongbao Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 25 annual periods. Check how aggressively does Tonghua Dongbao Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tonghua Dongbao Pharmaceutical Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Tonghua Dongbao Pharmaceutical Co Ltd from 2000 to 2025. For live market cap and broader valuation context, see 600867 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.75x | CN¥689.23 Million | CN¥517.69 Million | ▼ -39.3% |
| 2024 | 1.24x | CN¥459.74 Million | CN¥568.73 Million | ▲ +206.1% |
| 2023 | 0.40x | CN¥861.52 Million | CN¥348.13 Million | ▼ -29.1% |
| 2022 | 0.57x | CN¥863.09 Million | CN¥491.63 Million | ▲ +7.6% |
| 2021 | 0.53x | CN¥1.13 Billion | CN¥600.75 Million | ▲ +31.6% |
| 2020 | 0.40x | CN¥1.19 Billion | CN¥479.59 Million | ▲ +58.1% |
| 2019 | 0.25x | CN¥1.15 Billion | CN¥293.13 Million | ▼ -71.1% |
| 2018 | 0.88x | CN¥876.94 Million | CN¥773.07 Million | ▲ +356.8% |
| 2017 | 0.19x | CN¥961.19 Million | CN¥185.50 Million | ▼ -66.0% |
| 2016 | 0.57x | CN¥725.76 Million | CN¥411.53 Million | ▼ -58.3% |
| 2015 | 1.36x | CN¥294.58 Million | CN¥400.09 Million | ▲ +163.6% |
| 2014 | 0.52x | CN¥205.89 Million | CN¥106.08 Million | ▼ -40.2% |
| 2013 | 0.86x | CN¥221.06 Million | CN¥190.36 Million | ▼ -30.8% |
| 2012 | 1.24x | CN¥194.32 Million | CN¥241.83 Million | ▲ +174.7% |
| 2010 | 0.45x | CN¥160.40 Million | CN¥72.66 Million | ▼ -4.8% |
| 2009 | 0.48x | CN¥166.20 Million | CN¥79.07 Million | ▼ -22.5% |
| 2008 | 0.61x | CN¥92.31 Million | CN¥56.67 Million | ▼ -71.3% |
| 2007 | 2.14x | CN¥120.94 Million | CN¥258.34 Million | ▲ +17.6% |
| 2006 | 1.82x | CN¥158.00 Million | CN¥286.90 Million | ▲ +40.3% |
| 2005 | 1.29x | CN¥92.23 Million | CN¥119.38 Million | ▼ -65.3% |
| 2004 | 3.73x | CN¥13.17 Million | CN¥49.08 Million | ▲ +193.0% |
| 2003 | 1.27x | CN¥45.51 Million | CN¥57.90 Million | ▼ -54.5% |
| 2002 | 2.79x | CN¥31.99 Million | CN¥89.41 Million | ▲ +270.9% |
| 2001 | 0.75x | CN¥117.73 Million | CN¥88.69 Million | ▼ -58.2% |
| 2000 | 1.80x | CN¥29.12 Million | CN¥52.46 Million | — |